- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
Medivis Announces $20 Million Series A Funding for Augmented Reality Surgery Project
The Series A funding is led by Thrive Capital.
Medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million Series A funding round led by Thrive Capital, with participation from Initialized Capital and Mayo Clinic. Additional investors include Bob Iger, Kevin Durant, Dr. Robert Spetzler, Hugo Barra and Coalition Operators.
Headquartered in New York City, Medivis has partnered with the nation's leading medical centers including MD Anderson Cancer Center, Providence Health, University of Pittsburgh Medical Center, Northwell Health and Cincinnati Children's Hospital. The company has also announced an expanded partnership with the Veterans Health Administration, the nation's largest integrated health system. The fundraise will be used to scale engineering, obtain regulatory clearances and globally commercialize across multiple specialties including neurosurgery, orthopedic surgery, interventional radiology and reconstructive surgery.
Continue reading this story here.
